LONDON (Reuters) - European and British regulators said on Wednesday they had found possible links between AstraZeneca's vaccine and very rare cases of blood clots, but reaffirmed its importance in protecting people against COVID-19.
A British government advisory group said the vaccine should not be given to the under 30s where possible, though an official said this was "really out of the utmost caution, rather than because we have any serious safety concerns".
Already a subscriber? Log in
Play, subscribe and stand a chance to win prizes worth over RM39,000! T&C applies.
Cancel anytime. Ad-free. Unlimited access with perks.
